Edwards Lifesciences Corp (EW)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	1,402,400	1,521,900	1,503,100	823,400	1,046,900
Revenue	US$ in thousands	5,997,700	5,362,000	5,219,100	4,382,800	4,333,200
Net profit margin		23.38%	28.38%	28.80%	18.79%	24.16%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $1,402,400K ÷ $5,997,700K
= 23.38%

The net profit margin of Edwards Lifesciences Corp has shown some fluctuations over the past five years. In 2023, the net profit margin decreased to 23.35% from 28.28% in 2022, marking a notable decline in profitability. This decline follows a general trend of decreasing margins since 2021, where the net profit margin was at its peak of 28.73%.

While the net profit margin in 2023 is lower than in the previous years, it still remains above the level seen in 2020 (18.77%). Despite the recent decline, the company has generally maintained a healthy level of profitability over the period under review. It is important for investors and stakeholders to monitor the company's future financial performance to determine if this decrease in profitability is a temporary fluctuation or part of a longer-term trend.